Literature DB >> 1460658

Character and origin of vacuoles induced in mammalian cells by the cytotoxin of Helicobacter pylori.

C E Catrenich1, M H Chestnut.   

Abstract

Cytotoxic activity of culture supernates of Helicobacter pylori is manifested by vacuolation of mammalian cells in vitro. The formation and maturation of toxin-induced vacuoles in HeLa cells has been studied to examine the possibility that they are autophagosomal in nature. Observation by light microscopy revealed that vacuoles originate in a perinuclear position, increasing in number and size until cell degeneration and lysis occur after 48 h. Ultrastructural study of mature vacuoles indicated the presence of a bounding membrane with contents consisting of degenerate cytoplasmic components and acid phosphatase activity. Confocal fluorescence imaging demonstrated acridine orange accumulation in the vacuoles of toxin-treated cells, indicating an acidic intravacuolar pH. These features are characteristic of autophagosomes. In addition, the size of vacuoles in living, acridine orange-stained cells tended to be inversely proportional to fluorescence intensity. Fluid phase endocytic markers were observed only rarely within nascent vacuoles. Over the succeeding 24 h, labelling of most vacuoles with these dyes was observed. This, along with the observation of intravacuolar acid phosphatase activity, provides evidence that vacuoles communicate at some point during their development with endocytically derived compartments. These observations provide direct evidence for an autophagic origin of these structures.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1460658     DOI: 10.1099/00222615-37-6-389

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  21 in total

1.  Fluorescence resonance energy transfer microscopy of the Helicobacter pylori vacuolating cytotoxin within mammalian cells.

Authors:  David C Willhite; Dan Ye; Steven R Blanke
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

2.  Identification of the Helicobacter pylori VacA toxin domain active in the cell cytosol.

Authors:  M de Bernard; D Burroni; E Papini; R Rappuoli; J Telford; C Montecucco
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

3.  Binding and internalization of the Helicobacter pylori vacuolating cytotoxin by epithelial cells.

Authors:  J A Garner; T L Cover
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

4.  Cellular vacuoles induced by Helicobacter pylori originate from late endosomal compartments.

Authors:  E Papini; M de Bernard; E Milia; M Bugnoli; M Zerial; R Rappuoli; C Montecucco
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

5.  Effect of the vacuolation of Helicobacter pylori.

Authors:  L Shi; X Hou; S Yi; J Zhang
Journal:  J Tongji Med Univ       Date:  2001

Review 6.  Carbohydrate-dependent defense mechanisms against Helicobacter pylori infection.

Authors:  Motohiro Kobayashi; Heeseob Lee; Jun Nakayama; Minoru Fukuda
Journal:  Curr Drug Metab       Date:  2009-01       Impact factor: 3.731

7.  Membrane channel structure of Helicobacter pylori vacuolating toxin: role of multiple GXXXG motifs in cylindrical channels.

Authors:  Sanguk Kim; Aaron K Chamberlain; James U Bowie
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-05       Impact factor: 11.205

Review 8.  Molecular mechanism of Helicobacter pylori-induced autophagy in gastric cancer.

Authors:  Fan Zhang; Cong Chen; Jike Hu; Ruiliang Su; Junqiang Zhang; Zhijian Han; Hao Chen; Yumin Li
Journal:  Oncol Lett       Date:  2019-10-10       Impact factor: 2.967

Review 9.  Roles of gastric mucin-type O-glycans in the pathogenesis of Helicobacter pylori infection.

Authors:  Motohiro Kobayashi; Heeseob Lee; Jun Nakayama; Minoru Fukuda
Journal:  Glycobiology       Date:  2009-01-15       Impact factor: 4.313

10.  Cytotoxic action of Serratia marcescens hemolysin on human epithelial cells.

Authors:  R Hertle; M Hilger; S Weingardt-Kocher; I Walev
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.